Clin2
NCT07749547Possibly a fitNot yet recruiting

Personalized exercise program for polymyalgia rheumatica

Polymyalgia Rheumatica (PMR)

Part of Bones, joints & muscles, Skin clinical trials.

This study tests a personalized rehabilitation program designed to reduce disease activity and increase physical activity for people with polymyalgia rheumatica (PMR). It aims to see if tailored exercise can help manage symptoms and improve daily function.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
50 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with or had a flare of polymyalgia rheumatica within the last 5 months.
  • You are 50 years or older at the time of diagnosis.
  • You have pain in both shoulders.
  • You have had elevated inflammation blood tests (CRP above 10 or ESR above 30) at diagnosis.
  • You have started medication treatment for PMR.
  • You are able to get a doctor's clearance to participate in physical activity.
  • You do not have fibromyalgia, certain nerve or muscle diseases, or an active uncontrolled infection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07010484Recruiting
New imaging tests for polymyalgia rheumatica

This trial tests if new imaging methods can help diagnose and treat polymyalgia rheumatica (PMR). It may be for you if you're over 50, have pain in your shoulders or hips, and haven't taken steroids for PMR in the last 2 months.

Aarhus
NCT07748195Not yet recruiting
Understanding DNA changes in polymyalgia rheumatica

This study looks at DNA changes in people with PMR to better understand the disease. It may help doctors find better ways to diagnose and treat PMR in the future.

NCT07279688Recruiting· Phase 3
Baricitinib plus steroids for polymyalgia rheumatica

This trial tests if adding baricitinib (a pill that calms inflammation) to standard steroids works better than steroids alone for people with polymyalgia rheumatica. It aims to improve symptoms and reduce steroid side effects.

Aix-en-Provence
NCT05479448Recruiting
Tracking what predicts response in new PMR or GCA

This study looks at people newly diagnosed with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) and uses their health and treatment information to learn what predicts how well treatment works. It may help your care in the future by improving which patients respond best and how.

Basel
NCT06841562Recruiting
Home Exercise and Anti-inflammatory Program for Early RA

This study tests if a home-based exercise program, combined with anti-inflammatory strategies, can help people newly diagnosed with rheumatoid arthritis manage their symptoms and improve health. It's a remote program, so you can participate from home.

Durham, North Carolina
NCT07286214Recruiting· Phase 4
Study of sarilumab for early polymyalgia rheumatica

This trial tests whether the drug sarilumab can help people with newly diagnosed or early relapsing polymyalgia rheumatica (PMR) reduce their need for prednisone. It aims to see if the combination is safer and more effective than prednisone alone.

Denver, Colorado

Hear when a new Polymyalgia Rheumatica (PMR) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.